已收盘 09-25 16:00:00 美东时间
-0.310
-1.71%
今日重点评级关注:康托·菲茨杰拉德:维持Abeona Therapeutics"超配"评级,目标价从28美元升至30美元;HC Wainwright & Co.:维持Oculis Holding"买入"评级,目标价从26美元升至39美元
09-21 16:25
Needham analyst Kyle Peterson reiterates NIQ Global Intelligence (NYSE:NIQ) with a Buy and maintains $21 price target.
09-18 18:10
The Goldman Sachs equity team has rebalanced its Long Duration Basket amid rising interest rates. Equities usually struggle to digest sharp increases in interest rates, with long duration growth stock...
09-13 22:12
Enhanced capabilities connect product attributes with market performance, helping brands and retailers understand shopper choice today and prepare for AI-mediated discovery NIQ (NYSE:NIQ), a leading consumer intelligence company, today announced the expansion of NIQ Product Insights (NPI) across We...
09-08 18:34
As of Sept. 2, 2026, three stocks in the communication services sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days w...
09-02 20:59
New solution will connect AI-driven discovery to consumer intent, product content, AI-driven traffic and sales conversion NIQ (NYSE:NIQ), a leading consumer intelligence company, today announced further advancements in its Agentic Commerce Measurement strategy through a collaboration with Similarweb...
09-02 18:49
今日重点评级关注:BTIG:维持Kazia Therapeutics"买入"评级,目标价从34美元升至40美元;摩根大通:维持Annexon"超配"评级,目标价从10美元升至14美元
09-02 14:07
今日重点评级关注:Ascendiant Capital:维持RenovoRx"买入"评级,目标价从14美元升至14.5美元;HC Wainwright & Co.:维持Generate Biomedicines"买入"评级,目标价从25美元升至30美元
08-31 18:14
Baird analyst Jeffrey Meuler maintains NIQ Global Intelligence (NYSE:NIQ) with a Outperform and raises the price target from $17 to $23.
08-28 18:59
今日重点评级关注:康托·菲茨杰拉德:维持Ultragenyx Pharmaceutical"超配"评级,目标价从96美元升至103美元;Canaccord Genuity:维持Ultragenyx Pharmaceutical"买入"评级,目标价从81美元升至83美元
08-21 11:40